[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Davita Healthcare Partners (DVA)

Davita Healthcare Partners (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,527,382
  • Shares Outstanding, K 63,800
  • Annual Sales, $ 13,643 M
  • Annual Income, $ 746,800 K
  • EBIT $ 2,838 M
  • EBITDA $ 3,553 M
  • 60-Month Beta 0.88
  • Price/Sales 0.84
  • Price/Cash Flow 8.24
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 29.57% (-0.84%)
  • Historical Volatility 58.53%
  • IV Percentile 12%
  • IV Rank 11.19%
  • IV High 58.93% on 08/04/26
  • IV Low 25.87% on 09/02/25
  • Expected Move (DTE 17) 3.23 (1.84%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 238
  • Volume Avg (30-Day) 4,095
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 70,162
  • Open Int (30-Day) 69,150
  • Expected Range 172.78 to 179.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $3.78
  • Number of Estimates 2
  • High Estimate $4.02
  • Low Estimate $3.54
  • Prior Year $2.51
  • Growth Rate Est. (year over year) +50.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.40 +2.69%
on 08/24/26
247.49 -28.88%
on 08/03/26
-64.08 (-26.69%)
since 07/31/26
3-Month
171.40 +2.69%
on 08/24/26
247.49 -28.88%
on 08/03/26
-18.35 (-9.44%)
since 05/29/26
52-Week
101.00 +74.27%
on 01/14/26
247.49 -28.88%
on 08/03/26
+39.98 (+29.39%)
since 08/28/25

Most Recent Stories

More News
Alebund Pharmaceuticals Announces 2026 Interim Results

SHANGHAI , Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its...

DVA : 176.01 (-2.58%)
DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease

More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizations

DVA : 176.01 (-2.58%)
What Berkshire Hathaway’s Latest 13F Says About Who’s Swimming Naked

Who’s swimming naked? Any investor that thinks they are a trader, and any trader who thinks they are an investor. There’s a big difference.

GOOG : 335.41 (-2.18%)
GOOGL : 339.35 (-2.09%)
LEN : 84.11 (-2.57%)
DHI : 144.56 (-1.92%)
BAC : 61.94 (-0.61%)
BRK.A : 756,650.00 (-0.18%)
BRK.B : 504.03 (-0.19%)
KR : 57.54 (-0.31%)
COF : 214.51 (-0.54%)
M : 21.96 (-0.23%)
DAL : 78.00 (-2.59%)
DVA : 176.01 (-2.58%)
Are Wall Street Analysts Bullish on DaVita Stock?

Though DaVita has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

XLV : 170.54 (-0.36%)
$SPX : 7,686.14 (-0.33%)
DVA : 176.01 (-2.58%)
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

DVA : 176.01 (-2.58%)
Stock Indices Fall from Early Highs and Settle Mixed

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.17%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.83%. September...

AMAT : 458.39 (-0.71%)
B : 44.83 (-1.42%)
ANET : 195.69 (+0.16%)
HL : 19.87 (-2.50%)
CDE : 20.78 (-1.66%)
TXN : 260.91 (+0.88%)
$IUXX : 29,456.97 (+0.08%)
AMGN : 429.88 (-0.59%)
ZNZ26 : 107-160 (-0.15%)
SHOP : 147.37 (-3.62%)
COMP : 10.56 (-3.74%)
ESU26 : 7,692.00 (-0.09%)
Stocks Supported by Stellar Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures...

AMAT : 458.39 (-0.71%)
B : 44.83 (-1.42%)
ANET : 195.69 (+0.16%)
HL : 19.87 (-2.50%)
CDE : 20.78 (-1.66%)
WYNN : 91.28 (-4.18%)
TXN : 260.91 (+0.88%)
$IUXX : 29,456.97 (+0.08%)
AMGN : 429.88 (-0.59%)
ZNZ26 : 107-160 (-0.15%)
SHOP : 147.37 (-3.62%)
COMP : 10.56 (-3.74%)
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook

DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook

DVA : 176.01 (-2.58%)
Strong Earnings Push the S&P 500 to New Record High

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures...

B : 44.83 (-1.42%)
ANET : 195.69 (+0.16%)
HL : 19.87 (-2.50%)
CDE : 20.78 (-1.66%)
WYNN : 91.28 (-4.18%)
$IUXX : 29,456.97 (+0.08%)
AMGN : 429.88 (-0.59%)
ZNZ26 : 107-160 (-0.15%)
SHOP : 147.37 (-3.62%)
COMP : 10.56 (-3.74%)
ESU26 : 7,692.00 (-0.09%)
CDW : 151.58 (+2.63%)
DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops

DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops

DVA : 176.01 (-2.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 183.66
2nd Resistance Point 182.01
1st Resistance Point 179.01
Last Price 176.01
1st Support Level 174.36
2nd Support Level 172.71
3rd Support Level 169.71

See More

52-Week High 247.49
Fibonacci 61.8% 191.53
Last Price 176.01
Fibonacci 50% 174.24
Fibonacci 38.2% 156.96
52-Week Low 101.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.